Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.
about
The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cellsObesity and cancer: mechanistic insights from transdisciplinary studiesMolecular mechanisms of ETS transcription factor-mediated tumorigenesisInflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancerRAS oncogenes: weaving a tumorigenic webPea3 transcription factor cooperates with USF-1 in regulation of the murine bax transcription without binding to an Ets-binding siteCyclooxygenase-2 and the inflammogenesis of breast cancer.COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situFunctional promoter -765 G > C variant in COX-2 gene is associated with the susceptibility of breast cancer in Chinese Han women.The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast Cancer.RETRACTED: Novel management of oral cancer: a paradigm of predictive oncology.COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer.Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerTargeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter.The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression.Oleocanthal, a phenolic derived from virgin olive oil: a review of the beneficial effects on inflammatory diseaseAssociation of the three common SNPs of cyclooxygenase-2 gene (rs20417, rs689466, and rs5275) with the susceptibility of breast cancer: an updated meta-analysis involving 34,590 subjects.Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis.Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomasPolyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells.Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients.1-{5-[4-(Hex-yloxy)phen-yl]-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl}ethanoneElevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator.1-[5-(4-Meth-oxy-phen-yl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethanoneHER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion.The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesisCytosolic phospholipase A2-α expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours.The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3.Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro.Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplificationCyclooxygenase 2 selective inhibitors in cancer treatment and prevention.Requirement of PEA3 for transcriptional activation of FAK gene in tumor metastasis.Study on cow ghee versus soybean oil on 7,12-dimethylbenz(a)-anthracene induced mammary carcinogenesis & expression of cyclooxygenase-2 & peroxisome proliferators activated receptor-γ in rats.Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.The role of Pea3 group transcription factors in esophageal squamous cell carcinoma.Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulationNon-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.Role of traditional and new biomarkers in breast carcinogenesis.Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch
P2860
Q24528155-07401E75-6F64-4185-8D80-E1FDCE4AC22CQ26786829-8F308F98-747A-45FB-8A41-98013CB61E49Q26829833-9B44D773-87FA-4899-857D-99223F129143Q28218639-87735642-3F38-482B-802B-10521DAF76E2Q28250360-497D5ED6-48FD-43C3-A0A0-A056C350A43EQ28512571-2B4DFD9C-AEBC-49A0-8DEB-45E27F69CE73Q30367680-DCAD046E-6C15-4CAD-B625-9B5DCCDCF222Q33317621-AAA271E6-FD93-4A4B-8C8C-7D9C64983C16Q33600759-844D707D-F0C3-4BCE-94DB-E076E57E6CD2Q33664316-1F020E09-D891-4EC1-A7EA-B01439F00443Q33723572-2CEFE12D-013C-4AB4-9801-8031324B4292Q33747000-C4CC635D-29EA-468D-BCFB-CC0ABF7184EFQ33760216-A3127A03-9568-4EFC-9CFA-0A56ACCC2FE0Q33762359-4BA8D56E-21DF-41F3-B9F6-155B9F0A3FEEQ33934350-AD98076F-A336-42DF-B0AD-0EE580DCEA40Q34072400-4F01AA39-0E28-46D1-BB08-AAE523F0C832Q34119332-64F3FC52-C173-4EA7-A351-7A1F10795BD5Q34182494-9B291A8C-F496-49C1-8CEF-DC6D0A74BA32Q34246553-334E673F-F9AF-4FC9-A753-25AE7EAD5717Q34300048-8B000DF2-DFA6-42C6-88D4-4C991F626F25Q34316720-68C38D99-E94F-44A4-BC72-ECE3976DD64BQ34317495-5F18D976-0FC7-4DF5-803B-B5EC58D4E050Q34378390-DF44C34E-9742-4E89-AA9C-32E694B1FDBCQ34446168-148773AE-B693-4CD8-A006-55FD3EBA1F31Q34479560-321EC4B7-26AA-49D2-8BFE-00A914F6B1DDQ34493341-36D13ED5-ED93-467C-B19F-52C87316128FQ34543740-95F1632E-3BEA-4242-B5A0-216635F265A0Q34718092-DAA1C242-631B-4257-BACD-F3A2A82B4D2AQ34908885-CF656AFC-AF7E-4D7A-A509-CBDA20FEBEA0Q34913841-792F3EC0-7F0D-4394-A193-D7B0AB7F6635Q35011895-38032E62-BF61-4474-928B-72C4B57C0CD3Q35048351-E6D582E5-B426-4012-84BC-2D30C08BD419Q35062822-E359E3A7-1E56-4DB4-9404-510EAE778177Q35083639-356A1182-D233-43F3-B1A3-0056EB31AA03Q35167866-78CAEE8C-9C04-47EE-B8B0-9E16067AF9F6Q35176423-F6FEC596-2E8E-489C-808E-60FBD2D85BD1Q35227086-DB6C9DDB-CF4C-4A67-B966-55233B684479Q35558109-5225563C-EBCE-433B-A17A-4CB8F2754989Q35572905-10F8F76D-B002-4E1D-86AF-6A114BA506D4Q35732971-D5C84223-751F-4EBB-8535-1843779B8DB2
P2860
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Cyclooxygenase-2 is overexpres ...... involvement of AP-1 and PEA3.
@en
type
label
Cyclooxygenase-2 is overexpres ...... involvement of AP-1 and PEA3.
@en
prefLabel
Cyclooxygenase-2 is overexpres ...... involvement of AP-1 and PEA3.
@en
P2093
P2860
P356
P1476
Cyclooxygenase-2 is overexpres ...... involvement of AP-1 and PEA3.
@en
P2093
Andrew J Dannenberg
Kotha Subbaramaiah
William Gerald
P2860
P304
18649-18657
P356
10.1074/JBC.M111415200
P407
P50
P577
2002-03-18T00:00:00Z